The effect of indomethacin 0.5% ophthalmic suspension in preventing surgically induced miosis during planned extracapsular cataract extraction.
The effect of topical Indomethacin 0.5% ophthalmic suspension in preventing surgically induced miosis during planned extracapsular cataract extraction is examined. Eighteen patients received Indomethacin per-operatively while 16 did not and served as controls. Our study failed to show any difference in per-operative pupil size between either group.
Kervick
G N
GN
Department of Ophthalmology, Royal Victoria Hospital, Belfast, Northern Ireland.
Johnston
P B
PB
D000287:Administration, Topical; D000368:Aged; D000369:Aged, 80 and over; D002387:Cataract Extraction / Q000009:adverse effects; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage / Q000627:therapeutic use*; D007431:Intraoperative Complications / Q000517:prevention & control; D008875:Middle Aged; D015877:Miosis / Q000209:etiology / Q000517:prevention & control*; D009883:Ophthalmic Solutions; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D011897:Random Allocation
D009883:Ophthalmic Solutions; D011448:Prostaglandin Antagonists; D007213:Indomethacin